| Accession Number | 0001193125-26-003095 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 17,168 | $0.00 | $0.00 | 40,501 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 5, 2026 | Sale | 9,289 | $25.10 | $233,125.10 | 31,212 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 51,212 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 5, 2026 | Sale | 10,821 | $25.10 | $271,573.55 | 40,391 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Unit | Derivative | Jan 5, 2026 | Exercise/Conversion | 17,168 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Restricted Stock Unit | Derivative | Jan 5, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 20,000 | Direct | โ | View Details |